Investments
5Portfolio Exits
1Partners & Customers
10About Olympus Corporation of the Americas
Olympus is a global precision technology, designing and delivering solutions in the business areas of Medical and Surgical Products, Scientific Solutions, and Cameras and Audio Products. Through this technology, Olympus aims to contribute to society every day by making people's lives healthier, safer and more fulfilling. Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation in Tokyo, Japan – is headquartered in Center Valley, Pa., and manages the Company's operations and business activities throughout North and South America.
Want to inform investors similar to Olympus Corporation of the Americas about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Olympus Corporation of the Americas News
Apr 26, 2020
Global Nondestructive Testing Services and Equipment market report functions as an established information source to provide a telescopic view of current market trends, situations, opportunities and status. This Nondestructive Testing Services and Equipment report also encompasses the data that includes market definition, classifications, applications, commitments, market drivers and market restrictions obtained using SWOT analysis. Analysis and estimates derived from the huge information gathered in this market report on Nondestructive Testing Services and Equipment are extremely necessary in order to dominate the market or create a mark on the market. The geometric and numerical data collected to generate this report are meant mostly by the graphs, tables and charts that make this report more user-friendly. When making key business decisions, you can rely on this market report from Nondestructive Testing Services and Equipment for sure. In addition, this market report gives customers an idea of the market drivers and restrictions extracted from SWOT analysis and also provide all the CAGR projections in the forecast period of 2019-2026. Global nondestructive testing services and equipment marketis expected to register a healthy CAGR in the forecast period 2018 to 2025. Thenew market report contains data for historic year 2016, the base year ofcalculation is 2017 and the forecast period is 2018 to 2025. Key Players: Global Nondestructive Testing Services andEquipment Market Olympus Corporation of the Americas, MISTRAS Group, Inc., PfinderKG, Intertek, NIKON METROLOGY, Ashtead Technology, Sonatest, Bosello HighTechnology, a Zeiss company, Pfinder Chemical USA, Pfinder Mexico and others. Table of Contents: Global Nondestructive TestingServices and Equipment Market ExecutiveSummary Segmentation: Global NondestructiveTesting Services and Equipment Market On the basis of type, the global nondestructive testingservices and equipment market is segmented into services and equipment.Services are further sub segmented into inspection, consulting, training andothers. Equipment are further sub segmented into ultrasonic test equipment,radiography test equipment, visual inspection equipment, magnetic particle testequipment, penetrant test equipment, eddy current testing equipment, acousticemission testing equipment and others. In 2018, services market segment isvalued to rule with the highest market share 2025. On the basis of mode of testing, the globalnondestructive testing services and equipment market is segmented into surfacetesting, volumetric testing, condition monitoring and integrity inspection. In2018, surface testing segment is valued to rule with the highest market share2025. On the basis of application, the global nondestructivetesting services and equipment market is classified into flaw detection, leakdetection, dimensional measurement, physical analysis, chemical analysis,plasma emission testing, corrosion emission testing, and others. Among these,in 2018 physical analysis dominated the market and the trend is expected toremain the same till 2025. On the basis of industry, the global nondestructive testingservices and equipment market is classified into automotive, oil and gas,energy and power, aerospace and defence and others. Among these, in 2018 oiland gas dominated the market and the trend is expected to remain the same till2025. Among these, in 2018 oil and gas dominated the market and the trend isexpected to remain the same till 2025. By Geography Reasons to Purchase this Report: Current and future of global Nondestructive TestingServices and Equipment market outlook in the developed and emerging markets The segment that is expected to dominate the market aswell as the segment which holds highest CAGR in the forecast period Regions/Countries that are expected to witness thefastest growth rates during the forecast period The latest developments, market shares, and strategiesthat are employed by the major market players Read More aboutThis Report at https://databridgemarketresearch.com/reports/global-nondestructive-testing-services-and-equipment-market/ About Data BridgeMarket Research: Data Bridge Market Research set forth itself as anunconventional and neoteric Market research and consulting firm withunparalleled level of resilience and integrated approaches. We are determinedto unearth the best market opportunities and foster efficient information foryour business to thrive in the market. Data Bridge endeavors to provideappropriate solutions to the complex business challenges and initiates aneffortless decision-making process. Contact:
Olympus Corporation of the Americas Investments
5 Investments
Olympus Corporation of the Americas has made 5 investments. Their latest investment was in Spiration as part of their Debt on September 9, 2009.
Olympus Corporation of the Americas Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/21/2009 | Debt | Spiration | $7M | No | ||
3/21/2008 | Unattributed VC - II | |||||
4/17/2006 | Unattributed VC | |||||
Other Investors | ||||||
Other Investors |
Date | 9/21/2009 | 3/21/2008 | 4/17/2006 | ||
|---|---|---|---|---|---|
Round | Debt | Unattributed VC - II | Unattributed VC | Other Investors | Other Investors |
Company | Spiration | ||||
Amount | $7M | ||||
New? | No | ||||
Co-Investors | |||||
Sources |
Olympus Corporation of the Americas Portfolio Exits
1 Portfolio Exit
Olympus Corporation of the Americas has 1 portfolio exit. Their latest portfolio exit was Spiration on June 25, 2010.
Olympus Corporation of the Americas Acquisitions
2 Acquisitions
Olympus Corporation of the Americas acquired 2 companies. Their latest acquisition was Cybersonics - Lithotripsy Systems on April 10, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
4/10/2018 | Acquired Unit | 1 | ||||
4/28/2017 | Other |
Date | 4/10/2018 | 4/28/2017 |
|---|---|---|
Investment Stage | Other | |
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acquired Unit | |
Sources | 1 |
Olympus Corporation of the Americas Partners & Customers
10 Partners and customers
Olympus Corporation of the Americas has 10 strategic partners and customers. Olympus Corporation of the Americas recently partnered with Vizient on February 2, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
2/2/2023 | Client | United States | 15:32 ET Olympus Awarded Vizient Contract for Smoke Evacuation Portfolio `` Containing surgical smoke is critical for the health and wellbeing of surgical staff , which is why we are very pleased to be able to offer the Olympus Corporation smoke control solutions to Vizient Inc. members as part of this collaboration , '' said Sean Ward , Vice President for Enterprise Solutions at Olympus Corporation of the Americas . | 2 | |
12/8/2022 | Supplier | United States | Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc. Dec 8, 2022. `` We are pleased with the positive clinical feedback we have received from our trusted physician customers in the U.S. and are thrilled to expand our global partnership with Inc. in the EMEA region . | 1 | |
5/31/2022 | Client | United States | Olympus Awarded Bronchoscopy Solutions Agreement with Premier, Inc. May 31, 2022. CENTER VALLEY , Pa. -LRB- May 31 , 2022 -RRB- - Olympus today announced it has been awarded a group purchasing agreement in the Single-Use Visualization Devices category for its single-use bronchoscope portfolio with Premier , Inc. . | 1 | |
5/19/2022 | Partner | ||||
4/4/2022 | Licensor |
Date | 2/2/2023 | 12/8/2022 | 5/31/2022 | 5/19/2022 | 4/4/2022 |
|---|---|---|---|---|---|
Type | Client | Supplier | Client | Partner | Licensor |
Business Partner | |||||
Country | United States | United States | United States | ||
News Snippet | 15:32 ET Olympus Awarded Vizient Contract for Smoke Evacuation Portfolio `` Containing surgical smoke is critical for the health and wellbeing of surgical staff , which is why we are very pleased to be able to offer the Olympus Corporation smoke control solutions to Vizient Inc. members as part of this collaboration , '' said Sean Ward , Vice President for Enterprise Solutions at Olympus Corporation of the Americas . | Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc. Dec 8, 2022. `` We are pleased with the positive clinical feedback we have received from our trusted physician customers in the U.S. and are thrilled to expand our global partnership with Inc. in the EMEA region . | Olympus Awarded Bronchoscopy Solutions Agreement with Premier, Inc. May 31, 2022. CENTER VALLEY , Pa. -LRB- May 31 , 2022 -RRB- - Olympus today announced it has been awarded a group purchasing agreement in the Single-Use Visualization Devices category for its single-use bronchoscope portfolio with Premier , Inc. . | ||
Sources | 2 | 1 | 1 |
Olympus Corporation of the Americas Team
13 Team Members
Olympus Corporation of the Americas has 13 team members, including current Chief Executive Officer, Chief Operating Officer, Nacho Abia.
Compare Olympus Corporation of the Americas to Competitors
SpineForm is developing a less invasive spinal deformity surgical treatment. SpineForm's HemiBridge is a spinal implant designed to help correct and straighten spinal deformities in growing children, without the need for a brace or extensive future spinal fusion surgeries.
Osso VR is a virtual reality surgical training technology company. It provides surgeons, sales teams, and other trainees with an on-demand training platform featuring realistic, haptic-enhanced interactions in an immersive training environment. The company was founded in 2016 and is based in Millbrae, California.
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.
TrialSpark is a clinical trial management software and drug development company. The company aims to accelerate the pace of clinical trials and bring down costs with a software platform that helps sites like hospitals manage trials and collect and analyze data. Per the company, it uses data from social media to find doctors and patients to participate. While it began as a clinical trial technology platform, in 2021, it signaled a move to using its technology for drug development through the acquisition of biologic and small-molecule drugs. TrialSpark began primarily as a technology company that aims to bring treatments to patients faster using technology that improves clinical trials and drug development. TrialSpark has scaled a network of trial sites by partnering with doctors to create clinical trial sites within their existing practices. TrialSpark runs trials out of these doctor practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology. Without variability in operations at the trial site level, TrialSpark cuts out the manual, time-intensive, and costly tasks that delay clinical trial timelines. By creating trial sites with doctors, TrialSpark unlocks the 98 percent of patients who have never been exposed to trials, boosting recruitment and enrollment rates and democratizing access.
Docbot provides powerful artificial intelligence (AI)-assisted image analysis solutions for transforming gastrointestinal (GI) disease diagnosis, prevention, and healthcare decision-making. Its product includes an AI-based computer-aided detection software platform, UltivisionAI. The company serves the healthcare industry mainly. It was founded in 2014 and is based in Irvine, California.
Focal develops, manufactures and commercializes synthetic, absorbable, liquid surgical sealants based on the company's polymer technology. The company's FocalSeal-L and FocalSeal-S surgical sealant products are currently being developed for use inside the body to seal leaks resulting from lung, neurological, cardiovascular and gastrointestinal surgery.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.